The multisystemic nature of systemic lupus erythematosus (SLE), its involvement of vital organs and its unpredictable disease course with exacerbations and remissions give rise to the possibility of development of irreversible changes in individual organs even at early phases of the disease, and particularly after several years. 1 Tissue and organ damage occurs as a consequence of the disease itself, the therapy applied (primarily corticosteroid and cytostatic), and the accompanying conditions and complications. Tissue and organ damage are associated with an increased risk of death. 2, 3 Adequate evaluation of disease activity, assessment of organ damage using the Systemic Lupus
All patients with SLE who were hospitalised in the Rheumatology Clinic, Institute "Niška Banja" during 2012/13, with the duration of the disease longer than six months, were eligible for this study.
The patients' diagnosis of SLE was made on the basis of the revised ACR criteria of 1997. 7 This cross-sectional study involved 83 patients with SLE (77 women and 6 men), with mean age of 45.8 ± 9.2 years and average disease duration of 10.6 ± 7.9 years.
Disease activity was assessed using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and the physician's global assessment. 8 The degree of organ damage was evaluated using the standardized damage index (SDI). 4 The SDI assesses damage in nine organ systems and three disease complications. It measures the presence of irreversible changes in the eyes, skin and neuropsychiatric, renal, pulmonary, cardiovascular, peripheral vascular, gastrointestinal and musculoskeletal systems, along with the presence of gonadal insufficiency, diabetes mellitus and malignancy. Each of the characteristics adds an appropriate number of points to the overall score and is precisely defined in the SDI glossary. The total possible score for the damage index is 47.
Based on the damage index value, the SLE patients were divided into two groups: a study group comprising 58 patients (69.9%) with organ damage (SDI ≥ 1); and a control group comprising 25 patients (30.1%) without organ damage (SDI = 0). At the disease onset, the two groups were homogenous regarding the factors of gender and age. Quality of life was assessed on the basis of the standardized Medical Outcome Survey Short Form 36 (SF-36). 5 In this study, the values of three summary domains were primarily considered: physical (SF-36P), mental (SF-36M) and general health (SF-36G). The SF-36 questionnaire contains 36 questions in total, grouped into eight domains, along with a question relating to status change. The responses are scored from 0 to 100, in accordance with the key that is made available, such that higher scores indicate better quality of life.
The severity of fatigue was assessed using the Fatigue Severity Scale (FSS). 9 The FSS consists of nine statements for which possible answers graded from 1 to 7 are presented. The questions in the FSS relate to the preceding 14 days. Fatigue is graded as serious if the average value on the Fatigue Severity Scale exceeds the grade of 4.
The following demographic factors were observed: gender, age, disease duration, age at disease onset, time elapsed until diagnosis and education level (0-12 years or over 12 years). The following clinical factors were observed: number of diagnostic criteria, SLEDAI, physician's global assessment, hypertension, proteinuria, antiphospholipid syndrome, osteopenia, osteoporosis, cardiovascular diseases, involvement of the kidneys and central nervous system (CNS), severity of fatigue and quality of life expressed in terms of the physical, mental and general health domains. The following serological factors were determined: presence of anti-double-stranded deoxyribonucleic acid (anti-dsDNA), antinucleosome and anti-C1q antibodies; and the levels of monocyte chemoattractant protein-1 (MCP-1) in the serum (sMCP-1) and urine (uMCP-1). The presence of antibodies was determined using the enzyme-linked immunosorbent assay (ELISA) test in an Alegria automated ELISA reader, manufactured by Orgentec The descriptive statistical analysis involved the following statistical parameters: arithmetic mean, standard deviation, range (minimum-maximum), absolute frequency (n) and structure index (%).
Using the analytical statistical methodology, the statistical significance of the differences in frequency of appearance of certain characteristics in all examinees and according to group was measured.
The statistical testing was done using the chi-square test, or
Fisher's test for frequencies below five units. Comparisons of the mean values of characteristics between the groups were made using the t test for independent samples. Pearson's correlation for parametric samples was used to measure the associations of particular characteristics, through correlation analysis. The predictive impact of individual variables on the dependent outcome variable was assessed using univariate and multivariate regression analyses. All the factors that were significant in the univariate model were included in a logistic multivariate analysis ("enter" method).
An evaluation error level of below 5% (P < 0.05) was used at the threshold of statistical significance.
RESULTS
The parametric characteristics of the examinees in the study and control group are shown in Table 1 . The patients in the study group with organ damage and SDI ≥ 1 were statistically significantly older than those in the control group (47.9 ± 8.7 versus 40.8 ± 8.5 years; t = 3.464; P = 0.001) and presented longer disease duration (12.1 ± 8.6 versus 7.3 ± 4.8 years; t = 2.617; P = 0.011).
We did not find any statistically significant difference in the age at disease onset between the groups studied (t = 1.056; P = 0.294), or any significant difference in time elapsed from the onset of symptoms to diagnosis (t = 0.725; P = 0.471).
The mean values of the activity index, SF-36 survey scores and fatigue scale are also presented in Table 1 . There was no significant difference between the groups studied regarding disease activity and severity of fatigue, but the group with organ damage had significantly lower quality of life than the controls.
The mean value of the damage index for all the SLE patients was anti-C1q antibodies (r = 0.260; P < 0.05), sMCP-1 (r = 0.318; P < 0.01) and uMCP-1 (r = 0.431; P < 0.001). Table 2 shows the results from univariate regression analysis on the independent demographic, serological, clinical and therapeutic parameters in the groups studied with and without organ damage. Among the demographic factors, the statistically significant independent factors favoring organ damage were the age of the examinees viewed as a continuous value (odds ratio, OR = 1.094; P = 0.002) and disease duration expressed as a continuous value (OR = 1.096; P = 0.015). Disease duration of over 10 years was recognized as a statistically significant risk factor, with a risk that was up to three times higher than that of disease duration of less than five years (OR = 3.368; P = 0.045). Among the clinical risk factors, disease activity (expressed as physician's global assessment grade) and severe fatigue were considered significant.
Regarding physician's global assessment, grade 1 was a risk factor six times higher than grade 0 (OR = 5.800; P = 0.014) and grade 2 (OR = 10.667; P = 0.007) was a risk factor ten times higher, and these results were considered statistically significant. The patients with scores over 4 on the fatigue scale were exposed to a risk of organ damage that was three times higher than those with values ≤ 4 on this scale (OR = 3.370; P = 0.047). Higher values for the physical (OR = 0.976; P = 0.011), mental (OR = 0.978; P = 0.022) and general health (OR = 0.972; P = 0.008) domain scores were statistically significant protection factors against organ damage.
Hydroxychloroquine use was a protection factor against organ damage (OR = 0.378; P = 0.048), while azathioprine treatment was a risk factor (OR = 9.143; P = 0.037). Serological factors, including the levels of anti-dsDNA, antinucleosome and anti-C1q antibodies, along with sMCP-1 and uMCP-1, were not found to be risk factors for organ damage. In this study, the patients with organ damage and SDI ≥ 1 were statistically significantly older than those without organ damage 14 and had longer disease duration. 15 In addition, neuropsychiatric and musculoskeletal changes were the most common ones, similar to what was reported from a study conducted in Portugal. 16 The percentage of cardiovascular events in the present study was within the range of values reported from a meta-analysis on the predictors of cardiovascular events among patients with SLE. 17 The SDI correlated positively with patient age, disease duration, disease activity and severity of fatigue but negatively with the summary domains of the SF-36 survey: physical, mental and general health. The data indicated that SLE patients with higher damage index had worse quality of life and greater severity of fatigue.
The results obtained so far have been divergent regarding the correlation between the degree of damage and quality of life. 5, 6, 18, 19, 20 In contrast to the disease activity index, the SDI did not
show correlations with anti-dsDNA, antinucleosome or anti-C1q antibodies, or with sMCP-1 and uMCP-1. Although serum and urine MCP-1 are good markers of disease activity, they were not shown here to be indicators of organ damage, and neither were antibody levels. 21, 22 The results from univariate analyses in the present study showed that age, longer disease duration (especially when it was over African-Caribbean and Indo-Asian origin) but also increased disease activity and renal and CNS involvement. 15 The time elapsed from the onset of symptoms to diagnosis, lower education levels and presence of a large number of criteria at diagnosis did not show statistical significance in the present study.
In a large international study by Bruce et al., 3 the socioeconomic status factor (represented as education) was not significantly associated with organ damage. It is very interesting to examine the use of cytostatic agents, corticosteroids and antimalarial agents for treating SLE, since their use can possibly be correlated with organ damage. Over recent years, increasing amounts of data on organ damage caused through use of corticosteroids and their cumulative dose have become available.
Thus, it has been recommended that doses of corticosteroids should be as low as possible. 1, 3, 16, 19, 22, 23 In the present study, use of corticosteroids was not shown to be a risk factor, as also seen in some other studies. 24 The same was seen in relation to mycophenolate mofetil and pulse doses of cyclophosphamide. Use of azathioprine was an independent risk factor, similar to what was reported by Sutton et al. 15 The favorable effects of hydroxychloroquine regarding organ damage prevention in cases of SLE that was obtained in the present study were shown to be similar to those observed in other investigations. 25, 26 Hypertension, coronary disease, stroke, presence of peripheral atherosclerosis, proteinuria, renal involvement, CNS involvement, osteopenia, or osteoporosis, could not be singled out as independent risk factors for cumulative organ damage, according to the results from univariate analysis in the present study.
The presence of antiphospholipid antibodies can predict the development of neuropsychiatric damage. 27 In this light, and based on the situation that 13 out of the 83 SLE cases in the present study presented antiphospholipid syndrome, the reason why no significant association was shown here was probably because of the smaller number of respondents or the therapy applied or the shorter duration of monitoring, in comparison with other investigations.
Quality of life, as a separate category, was analyzed in some studies, bearing in mind that SLE is a chronic disease. 28, 29 In the present study, quality of life was assessed using the standardized Medical Outcome Survey Short Form 36. The results from univariate and multivariate analysis showed that better quality of life, especially within the physical and mental domains, was associated with a lower degree of organ damage. The main determinant of organ damage, according to some studies, is overall disease activity. 30, 31, 32 The multivariate analysis in the present study showed that disease activity evaluated on the basis of physician's global assessment was the most important risk factor for organ damage.
The strength of the present study is the fact that many parameters were taken into consideration as potential risk factors for organ damage in SLE patients: demographic, clinical, therapeutic and serological. Most other studies did not consider such a wide range of parameters. One limitation of our study was the number of participants. Future prospective study with larger numbers of participants, in which demographic, clinical, therapeutic and serological parameters are monitored, should provide stronger evidence of risk factors for organ damage in SLE patients.
CONCLUSION
Although this study was based on a relatively small number of respondents, it showed that the risk factors for organ damage were age, disease duration (especially when this was over 10 years), disease activity, use of azathioprine and severe fatigue. The factors affording protection against organ damage were use of hydroxychloroquine and better quality of life, as expressed through physical, mental and general health scores in a SF-36 survey.
Physician's global assessment has a prominent place in the evaluation of disease activity, since it is a simple method and is the most important predictor of organ damage in everyday clinical practice.
